Good news for insulin users: the United States FDA has approved the first generic glucagon rescue injection. Soon that vital and occasionally…
Tag: Glucagon
When our daughter, Bisi, was first diagnosed with type 1 diabetes, we received three days of intensive training in the hospital before we were allowed…
On the heels of the approval of nasal glucagon, the FDA has approved Xeris Pharmaceuticals’ ready-to-use, room-temperature stable liquid…
Who’s got your back? Who have you trained on your emergency Glucagon kit? When you – or the person with Type 1 diabetes in your life – has a severe hypo,…
The U.S. Food and Drug Administration (FDA) has approved Lilly’s BAQSIMI (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia…
Most people who follow developments in the diabetes world have probably heard about efforts to create smart insulin, which would sense when blood…
While insulin and insulin pumps have evolved into highly technical and effective tools for treating diabetes, the method for delivering emergency…
Novo Nordisk Inc. is recalling six batches of the GlucaGen HypoKit in the U.S. due to two customer complaints from the UK and Portugal involving…
Another insulin coming to us in 2016 is Lilly’s new basal insulin, Basaglar – a form of insulin glargine (which you may recognize if you’re familiar with Lantus). FDA approved it just this week after a patent dispute was finally resolved with Sanofi.
In anticipation of stable, liquid glucagon, one of the newest entrants into the insulin pump space, Tandem Diabetes Care has jumped ahead of the crowd and created a two-chamber infusion pump capable of holding and injecting both insulin and a secondary hormone, which they expect will be glucagon. This tandem Tandem pump is already being tested in Dr. Ed Damiano's clinical trial of a dual-hormone bionic pancreas.